tolvaptan
Selected indexed studies
- Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial. (Clin J Am Soc Nephrol, 2023) [PMID:36719158]
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. (J Am Soc Nephrol, 2018) [PMID:30228150]
- Tolvaptan and urea in paediatric hyponatraemia. (Pediatr Nephrol, 2024) [PMID:37466863]
_Worker-drafted node — pending editorial review._
Connections
tolvaptan is a side effect of
Sources
- Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial. (2023) pubmed
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. (2018) pubmed
- Tolvaptan and urea in paediatric hyponatraemia. (2024) pubmed
- Tolvaptan. (2010) pubmed
- Tolvaptan for Volume Management in Heart Failure. (2019) pubmed
- Tolvaptan for water retention in heart failure: a systematic review. (2023) pubmed
- Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease. (2019) pubmed
- Tolvaptan-related toxicoderma. (2024) pubmed
- [ADPKD treatment: Tolvaptan and Octreotide]. (2019) pubmed
- Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis. (2019) pubmed